Profil
George D.
Maynard is currently the President & Chief Scientific Officer at Renetx Bio, Inc. He previously worked as the Vice President-Early Development at Neurogen Corp., Head-Medicinal Chemistry at DuPont Pharmaceuticals Co., and Senior Associate Scientist at Hoechst Marion Roussel, Inc. and the University of Cincinnati Research Institute.
Maynard completed his undergraduate degree at Marietta College and holds a doctorate from The Ohio State University.
Postes actifs de George D. Maynard
| Sociétés | Poste | Début |
|---|---|---|
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | President | - |
Anciens postes connus de George D. Maynard
| Sociétés | Poste | Fin |
|---|---|---|
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Corporate Officer/Principal | - |
Hoechst Marion Roussel, Inc.
Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Corporate Officer/Principal | - |
University of Cincinnati Research Institute
University of Cincinnati Research Institute Miscellaneous Commercial ServicesCommercial Services The University of Cincinnati Research Institute (UCRI), established in 2010, is a nonprofit contracting organization affiliated with the University of Cincinnati Office of Research. The non-profit company is based in Cincinnati, OH. It specializes in facilitating research partnerships between university experts and industry by managing complex contracts, including international agreements and nontraditional payment terms. UCRI supports diverse fields such as cybersecurity and advanced manufacturing, providing tailored contract solutions that enable researchers to focus on their work. The CEOs of the company are David Adams, Patrick Limbach. | Corporate Officer/Principal | - |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Corporate Officer/Principal | - |
Formation de George D. Maynard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Health Technology |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Health Technology |
Marietta College
Marietta College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hoechst Marion Roussel, Inc.
Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Health Technology |
University of Cincinnati Research Institute
University of Cincinnati Research Institute Miscellaneous Commercial ServicesCommercial Services The University of Cincinnati Research Institute (UCRI), established in 2010, is a nonprofit contracting organization affiliated with the University of Cincinnati Office of Research. The non-profit company is based in Cincinnati, OH. It specializes in facilitating research partnerships between university experts and industry by managing complex contracts, including international agreements and nontraditional payment terms. UCRI supports diverse fields such as cybersecurity and advanced manufacturing, providing tailored contract solutions that enable researchers to focus on their work. The CEOs of the company are David Adams, Patrick Limbach. | Commercial Services |
















